{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:50:22Z","timestamp":1740167422011,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81770011, 31771004"],"award-info":[{"award-number":["81770011, 31771004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese National Mega Science and Technology Program on Infectious Diseases","award":["2018ZX10302301, 2018ZX10731301"],"award-info":[{"award-number":["2018ZX10302301, 2018ZX10731301"]}]},{"name":"National Key R&D Program of China","award":["2018YFD0500900"],"award-info":[{"award-number":["2018YFD0500900"]}]},{"name":"Clinical Research Plan of SHDC","award":["16CR2041B"],"award-info":[{"award-number":["16CR2041B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40121-021-00435-5","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T18:06:21Z","timestamp":1617818781000},"page":"925-937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety Evaluation of Recombinant Fusion Protein RP22 as a Skin Test Reagent for Tuberculosis Diagnosis: A Phase\u00a0I Clinical Trial"],"prefix":"10.1007","volume":"10","author":[{"given":"Lu","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang-yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-hong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"435_CR1","unstructured":"WHO. Global tuberculosis report 2019. Geneva: World Health Organization; 2019."},{"key":"435_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372:2127\u201335.","journal-title":"N Engl J Med"},{"key":"435_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thorax.57.9.804","volume":"57","author":"L Wang","year":"2002","unstructured":"Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804\u20139.","journal-title":"Thorax"},{"key":"435_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2016.10357","volume":"316","author":"LC Kahwati","year":"2016","unstructured":"Kahwati LC, Feltner C, Halpern M, et al. Primary care screening and treatment for latent tuberculosis infection in adults: evidence report and systematic review for the US preventive services task force. JAMA. 2016;316:970\u201383.","journal-title":"JAMA"},{"key":"435_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10156-009-0686-8","volume":"15","author":"T Mori","year":"2009","unstructured":"Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother. 2009;15:143\u201355.","journal-title":"J Infect Chemother"},{"key":"435_CR6","doi-asserted-by":"crossref","unstructured":"Pai M. Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol. 2010;8:242.","DOI":"10.1038\/nrmicro2236-c1"},{"key":"435_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","volume":"174","author":"M Pai","year":"2006","unstructured":"Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174:349\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"435_CR8","first-page":"84","volume":"13","author":"M Pai","year":"2009","unstructured":"Pai M, Joshi R, Dogra S, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis. 2009;13:84\u201392.","journal-title":"Int J Tuberc Lung Dis"},{"key":"435_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)30436-2","volume":"5","author":"M Ruhwald","year":"2017","unstructured":"Ruhwald M, Aggerbeck H, Gallardo RV, et al. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon gamma release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Respir Med. 2017;5:259\u201368.","journal-title":"Lancet Respir Med"},{"key":"435_CR10","doi-asserted-by":"publisher","first-page":"e0208705","DOI":"10.1371\/journal.pone.0208705","volume":"13","author":"L Slogotskaya","year":"2018","unstructured":"Slogotskaya L, Bogorodskaya E, Ivanova D, Sevostyanova T. Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow. PLoS One. 2018;13:e0208705.","journal-title":"PLoS One"},{"issue":"4","key":"435_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","volume":"5","author":"JR Andrews","year":"2017","unstructured":"Andrews JR, et al. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. Lancet Respir Med. 2017;5(4):282\u201390.","journal-title":"Lancet Respir Med"},{"key":"435_CR12","first-page":"2744","volume":"37","author":"X Wei","year":"2012","unstructured":"Wei X, Xie YM. [Principle of adverse drug reaction causality judgement and interpretation of causality assessment method both in China and abroad]. Zhongguo Zhong Yao Za Zhi. 2012;37:2744\u20137.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"435_CR13","unstructured":"World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO: Geneva: 2014."},{"key":"435_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S2213-2600(17)30012-7","volume":"5","author":"I Abubakar","year":"2017","unstructured":"Abubakar I, Jackson C, Rangaka MX. C-Tb: a latent tuberculosis skin test for the 21st century? Lancet Respir Med. 2017;5:236\u20137.","journal-title":"Lancet Respir Med"},{"key":"435_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2249.2008.03605.x","volume":"152","author":"X Wu","year":"2008","unstructured":"Wu X, Zhang L, Zhang J, Zhang C, Zhu L, Shi Y. Recombinant early secreted antigen target 6 protein as a skin test antigen for the specific detection of Mycobacterium tuberculosis infection. Clin Exp Immunol. 2008;152:81\u20137.","journal-title":"Clin Exp Immunol"},{"key":"435_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1128\/CDLI.5.4.531-536.1998","volume":"5","author":"N Desem","year":"1998","unstructured":"Desem N, Jones SL. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol. 1998;5:531\u20136.","journal-title":"Clin Diagn Lab Immunol"},{"key":"435_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.12659\/MSMBR.883912","volume":"19","author":"WX Du","year":"2013","unstructured":"Du WX, Chen BW, Lu JB, et al. Preclinical study and phase\u00a0I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein. Med Sci Monit Basic Res. 2013;19:146\u201352.","journal-title":"Med Sci Monit Basic Res"},{"key":"435_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1128\/CDLI.7.2.155-160.2000","volume":"7","author":"LA van Pinxteren","year":"2000","unstructured":"van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol. 2000;7:155\u201360.","journal-title":"Clin Diagn Lab Immunol"},{"key":"435_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tube.2007.11.004","volume":"88","author":"SM Arend","year":"2008","unstructured":"Arend SM, Franken WP, Aggerbeck H, et al. Double-blind randomized phase\u00a0I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis (Edinb). 2008;88:249\u201361.","journal-title":"Tuberculosis (Edinb)"},{"key":"435_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tube.2008.09.007","volume":"89","author":"T Lillebaek","year":"2009","unstructured":"Lillebaek T, Bergstedt W, Tingskov PN, et al. Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique. Tuberculosis (Edinb). 2009;89:158\u201362.","journal-title":"Tuberculosis (Edinb)"},{"key":"435_CR21","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1128\/IAI.71.9.4901-4907.2003","volume":"71","author":"MA Skinner","year":"2003","unstructured":"Skinner MA, Buddle BM, Wedlock DN, et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect Immun. 2003;71:4901\u20137.","journal-title":"Infect Immun"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"e11277","DOI":"10.1371\/journal.pone.0011277","volume":"5","author":"W Bergstedt","year":"2010","unstructured":"Bergstedt W, Tingskov PN, Thierry-Carstensen B, et al. First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent. PLoS One. 2010;5:e11277.","journal-title":"PLoS One"},{"key":"435_CR23","doi-asserted-by":"crossref","unstructured":"Aggerbeck H, Giemza R, Joshi P, et al. Randomised clinical trial investigating the specificity of a novel skin test (C-Tb) for diagnosis of M. tuberculosis infection. PLoS One. 2013;8:e64215.","DOI":"10.1371\/journal.pone.0064215"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00435-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-021-00435-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00435-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:28:27Z","timestamp":1620847707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-021-00435-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1007\/s40121-021-00435-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"type":"print","value":"2193-8229"},{"type":"electronic","value":"2193-6382"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}